You are here

Article info

Article menu

Download PDFPDF

PostScript
Letter
Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies

Authors

  • Giulia Berzero Service de Neurologie 2-Mazarin, AP-HP Groupe Hospitalier Pitié-Salpêtrière, Paris, France Neuroscience Consortium, University of Pavia, Monza Policlinico, and Pavia Mondino, Italy PubMed articlesGoogle scholar articles
  • Evgenia Karantoni Service de Neurologie 2-Mazarin, AP-HP Groupe Hospitalier Pitié-Salpêtrière, Paris, France PubMed articlesGoogle scholar articles
  • Caroline Dehais Service de Neurologie 2-Mazarin, AP-HP Groupe Hospitalier Pitié-Salpêtrière, Paris, France PubMed articlesGoogle scholar articles
  • François Ducray Centre de Référence National pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Lyon, France PubMed articlesGoogle scholar articles
  • Laure Thomas Centre de Référence National pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Lyon, France PubMed articlesGoogle scholar articles
  • Géraldine Picard Centre de Référence National pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Lyon, France PubMed articlesGoogle scholar articles
  • Véronique Rogemond Centre de Référence National pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Lyon, France PubMed articlesGoogle scholar articles
  • Gaëlle Candelier Service de Neurologie 2-Mazarin, AP-HP Groupe Hospitalier Pitié-Salpêtrière, Paris, France PubMed articlesGoogle scholar articles
  • Jean-Philippe Camdessanché Service de Neurologie, Hôpital Nord, CHU Saint-Etienne, Saint-Etienne, France Université Claude Bernard Lyon 1, F-69372, Université de Lyon, Lyon, France Institut NeuroMyoGene, INSERMU1217/CNRS UMR 5310, Lyon, France PubMed articlesGoogle scholar articles
  • Jean-Christophe Antoine Service de Neurologie, Hôpital Nord, CHU Saint-Etienne, Saint-Etienne, France Institut NeuroMyoGene, INSERMU1217/CNRS UMR 5310, Lyon, France Université Claude Bernard Lyon 1, F-69372, Université de Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Jérôme De Seze Service de Neurologie, Hôpital Civil, Strasbourg, France PubMed articlesGoogle scholar articles
  • Amélie Liou-Schischmanoff Service Pharmacie, Pôle SPEPS, Hôpitaux Universitaires Pitié Salpetrière–Charles Foix, Paris, France PubMed articlesGoogle scholar articles
  • Jérôme Honnorat Centre de Référence National pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Lyon, France Institut NeuroMyoGene, INSERMU1217/CNRS UMR 5310, Lyon, France Université Claude Bernard Lyon 1, F-69372, Université de Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Jean-Yves Delattre Service de Neurologie 2-Mazarin, AP-HP Groupe Hospitalier Pitié-Salpêtrière, Paris, France Centre de Recherche de l’Institut du Cerveau et de la Moelle Epinière (CRICM), UMRS 975, Université Pierre et Marie Curie - Paris VI, Paris, France PubMed articlesGoogle scholar articles
  • Dimitri Psimaras Service de Neurologie 2-Mazarin, AP-HP Groupe Hospitalier Pitié-Salpêtrière, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Dimitri Psimaras, Service de Neurologie 2-Mazarin, AP-HP Groupe Hospitalier Pitié-Salpêtrière, 47-83 Boulevard de l’Hôpital, Paris 75013, France; dimitri.psimaras{at}aphp.fr
View Full Text

Citation

Berzero G, Karantoni E, Dehais C, et al
Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies
Journal of Neurology, Neurosurgery & Psychiatry 2018;89:789-792.

Publication history

  • Received July 19, 2017
  • Revised September 20, 2017
  • Accepted October 2, 2017
  • First published October 30, 2017.
Online issue publication 
June 14, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/